Controlled Human Infection

2

Review clinical trials related to Controlled Human Infection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults

A Controlled Human Infection Model (CHIM) is being developed to provide early proof-of-concept that experimental infection with the intestinal nematode, Trichuris trichiura, is feasible and safe. The proposed model consists of enrolling consenting, healthy, trichuriasis-naïve adults and challenging them with the investigational product, Trichuris trichiura Egg Inoculum, to assess their ability to result in detectable infection. The proposed study will be a feasibility study that will consist of administering different doses of the Trichuris trichiura Egg Inoculum to healthy adult volunteers to determine the optimal dose (i.e., number of T. trichiura eggs) that is safe, well-tolerated and results in consistent infection.

Participants needed: 18
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: George Washington UniversityUpdated: Jun 4, 2026Locations: 2
Eligibility criteria

Males or females between 18 and 45 years, inclusive. [+4]

Pregnancy as determined by a positive urine human choriogonadotropin (hCG) (if f... [+21]

Status: Not yet recruiting

Clostridioides Difficile Controlled Human Infection Model

This study will investigate in healthy study subjects, the safety and tolerability of a controlled infection with Clostridioides difficile, a gut bacterium that can cause diarrhoea. It is also examined which dosing regimen (with or without antibiotic pretreatment) is required to induce mild symptoms (like diarrhoea) in the majority of study subjects and which microbiota and immunological factors influence this. To investigate this, healthy adult study subjects will be asked to ingest capsules (pills) containing the Clostridioides bacterium.

Participants needed: 60
Trial details
Age: 18-45Biological sex: AllType: InterventionalSponsor: Leiden University Medical CenterUpdated: Nov 22, 2024Locations: 1
Eligibility criteria

Subject is aged ≥18 and ≤45 years and in good health; [+5]

Any physical or psychiatric illness or conditions that could threaten or com-pro... [+19]